Clinical Trials Management System Market Report 2022 to 2030
A clinical trial management system (CTMS) is a software system used to manage clinical trials in clinical research. We offer pre-clinical discovery support services, research testing analysis for medical research studies and research facilities
Market Overview
- The global clinical trials management system market size is anticipated to reach USD 4.72 billion by 2030
- The market is expected to expand at a notable CAGR of 13.9% from 2022 to 2030
- The segments covered in the report solution type, delivery mode, component, end user, region
Solution Type
Delivery Mode
- Web & Cloud-based
- On-premise
Component
End User
- Pharmaceutical and Biotechnology Firms
- Medical Device Firms
- Others
Region
North America
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
Latin America
MEA
- South Africa
- Saudi Arabia
Clinical Trials Management System Market Report Highlights
- A CAGR of 13.9% is predicted for the Clinical Trials Management System (CTMS) market, which had a 2021 market size of USD 1.50 billion
- The increasing demand for interoperable solutions and adoption of AI and machine learning (ML) in healthcare are other key factors fueling market growth
- This is owing to increasing adoption of cloud-based technologies and enterprise-wide applications of CTMS solutions
Key Factors
- Outsourcing of clinical trials
Growth in the number of clinical trials
- With the advancement in technology and the growing demand for better drugs with fewer side effects, there has been a rise in the number of clinical trials conducted worldwide.
- And increasing number of clinical trials boosts the growth of the clinical trial management market
- Awareness regarding the benefits of CTM software
- Incidences of chronic diseases
- Research & development